In this issue a series of outstanding and comprehensive reviews of the progress of electrophysiological biomarkers or endophenotype indicators in psychiatric illnesses is presented. These reviews establish presence of electrophysiological abnormalities in symptom-based diagnoses of schizophrenia, dementia, anxiety disorders, substance abuse, and childhood disorders. Diagnostic sensitivity and specificity remain modest in most studies as may be expected for the relationship of indicators of underlying dimensions of brain organization and function when compared by interview-obtained symptom assessment. The power of electrophysiology to mirror pharmacological effects and treatment susceptability is an important resarch direction for electrophysiology.
BlackwoodDHWhalleyLJChristieJEBlackburnIMSt. ClairDMMcInnesA. Changes in auditory P3 event-related potential in schizophrenia and depression. Br J Psychiatry1987; 150: 154–160.
2.
BobesMALeiZXIbañezSYiHValdes-SosaM. Semantic matching of pictures in schizophrenia: a cross-cultural ERP study. Biol Psychiatry1996; 40(3): 189–202.
3.
SnyderSMQuintanaHSexsonSBKnottPHaqueAFReynoldsDA. Blinded, multi-center validation of EEG and rating scales in identifying ADHD within a clinical sample. Psychiatry Res2008; 159(3): 346–358.
4.
GoodingDCBurroughsSBoutrosNN. Attentional deficits in cocaine-dependent patients: converging behavioral and electrophysiological evidence. Psychiatry Res2008; 160(2): 145–154.
5.
SkosnikPDParkSDobbsLGardnerWL. Affect processing and positive syndrome schizotypy in cannabis users. Psychiatry Res2008; 157(1–3): 279–282.
6.
GottesmanIIGouldTD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry2003; 160(4): 636–645.
7.
RosburgTNNBoutrosNNFordJM. Reduced auditory evoked potential component N100 in schizophrenia — a critical review. Psychiatry Res2008; 161(3): 259–274.
8.
WrightMJLucianoMHansellNKMontgomeryGWGeffenGMMartinNG. QTLs identified for P3 amplitude in a non-clinical sample: importance of neurodevelopmental and neurotransmitter genes. Biol Psychiatry2008; 63(9): 864–873.
9.
WangYHuYFangYAhangKYangHMaJEvidence of epistasis between the catechol-o-methyltransferase and aldehyde dehydrogenase 3B1 genes in paranoid schizophrenia. Biol Psychiatry2009. Epub.
10.
BuchsbaumMSHaierRJ. Psychopathology: biological approaches. Annu Rev Psychol1983; 34: 401–430.
11.
MolinaVReigSSanzJPalomoTBenitoCSarrameaFDifferential clinical, structural and P300 parameters in schizophrenia patients resistant to conventional neuroleptics. Prog Neuropsychopharmacol Biol Psychiatry2008; 32(1): 257–266.
12.
FrommannIBrinkmeyerJRuhrmannSHackEBrockhaus-DumkeABechdolfAAuditory P300 in individuals clinically at risk for psychosis. Int J Psychophysiol2008; 70(3): 192–205.
13.
OzgurdalSGudlowskiYWitthausHKawohlWUhlIHauserMReduction of auditory event-related P300 amplitude in subjects with at-risk mental state for schizophrenia. Schizophr Res2008; 105(1–3): 272–278.
14.
StroupTSLiebermanJAMcEvoyJPSwartzMSDavisSMRosenheckRAEffectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. Am J Psychiatry2006; 163(4): 611–622.
15.
JuckelGPogarellOAugustinHMulertCMuller-SiechenederFFrodlTDifferential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. J Clin Psychiatry2007; 68(8): 1206–1212.
16.
HegerlUJuckelGMuller-SchubertAPietzckerAGaebelW. Schizophrenics with small P300: a subgroup with a neurodevelopmental disturbance and a high risk for tardive dyskinesia?Acta Psychiatr Scand1995; 91(2): 120–125.
